Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma: Translational and Clinical Outcomes, Volume Three provides comprehensive information about ongoing research and clinical data on liver cancer. The book presents detailed descriptions about diagnostics and therapeutic options for easy understanding, with a focus on precision medicine approaches to improve treatment outcomes. This updated volume discusses topics such as clinical and safety assessment of HCC patients, liver transplantation as a therapeutic option, immunotherapy interventions, and image-based surveillance. In addition, it discusses immunohistology of HCC-enabled precision medicine and artificial intelligence for hepatocellular carcinomas. This is a valuable resource for cancer researchers, oncologists, graduate students, hepathologists and members of biomedical research who need to understand more about liver cancer to apply in their research work or clinical setting.
Dr. Nagaraju GP is a faculty member in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Nagaraju obtained his MSc and his PhD, both in Biotechnology, from Sri Venkateswara University in Tirupati, Andhra Pradesh, India. Dr. Nagaraju received his DSc from Berhampur University in Berhampur, Odisha, India. Dr. Nagaraju's research focuses on translational projects related to gastrointestinal malignancies. He has published over 70 research papers in highly reputed International journals and has presented more than 50 abstracts at various national and international conferences. Dr, Nagaraju is author and editor of several published books including 1. Role of Tyrosine Kinases in Gastrointestinal Malignancies, 2. Role of Transcription Factors in Gastrointestinal Malignancies and 3. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy. He serves as editorial board member of several internationally recognized academic journals. Dr. Nagaraju is an associate member of the Discovery and Developmental Therapeutics research program at Winship Cancer Institute. Dr. Nagaraju has received several international awards including FAACC. He also holds memberships with the Association of Scientists of Indian Origin in America (ASIOA), the Society for Integrative and Comparative Biology (SICB), The Science Advisory Board, The RNA Society, The American Association for Clinical Chemistry (AACC) and the American Association of Cancer Research (AACR). Doctor Sarfraz Ahmad is Director of Clinical Research at the Gynecologic Oncology Department of the Advent Health (formerly Florida Hospital) Cancer Institute (AHCI), Orlando, FL, USA. He earned his PhD degree in Biochemistry from North-Eastern Hill University, Shillong. Before joining AHCI in 2002, he spent 2-years at the Indian Institute of Technology-Delhi as a researcher, and 10-years in research/teaching at the Loyola University of Chicago and the University of Illinois at Chicago's Division of Hematology/Oncology, College of Medicine. Currently, he is Professor of Medical Education at the University of Central Florida, College of Medicine and Professor of Clinical Sciences at the Florida State University College of Medicine, Orlando, USA. He has trained numerous fellows, residents, medical students, and graduate/undergraduate students during their scholarly research projects and theses. Dotor Ahmad's current research focus is on the analyses of clinico-pathologic and surgical outcomes of oncology/hematology patients and to better understand the cellular/molecular mechanisms of cancer and related thrombo-embolic/hematologic disorders. His investigations are also aimed towards the evaluation of novel treatment options (chemo/cellular/immuno-therapies) for better management of hemato-oncologic patients. His past research interests focused on the anticoagulants, antithrombin, antiplatelet, and thrombolytic drug development for the management of hematologic and cardiovascular patients. In these various areas of biomedical research and international collaborations, Dr. Ahmad has published over 200 peer-reviewed scholarly research articles and book chapters, and nearly 400 scientific abstracts, which are extensively cited globally. He is a reviewer and has editorial responsibilities for several biomedical journals/books; he has received several competitive research grants and national/international awards for his research contributions/accomplishments. In addition to biomedical science endeavors, Dr. Ahmad is passionate about classical Hindi-Urdu literature & poetry and takes pride with active participation in such forums.
Title: Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3: Translational and Clinical Outcomes
Author:
ISBN: 9780323992831
Binding:
Publisher: Elsevier Science & Technology
Publication Date: 2022-04-21
Number of Pages: 468
Weight: 0.4501 kg
